Sign inJoin waitlistJoin the waitlist

SK

Stephen Keefe

Adjunct Assistant Professor · University of Pennsylvania Health System

Credentials: · ·

History

University of Pennsylvania Health System
Present

Hematology and Medical Oncology
2006–2009
Internal Medicine
2003–2006
Doctor of Medicine
1999–2003

Research

First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2…
The Lancet Oncology · 2017 · 1,061 citations
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
New England Journal of Medicine · 2021 · 855 citations
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer
New England Journal of Medicine · 2022 · 797 citations

David Vaughn
7 papers
Bruce Malkowicz
6 papers
Thomas Guzzo
6 papers
John Christodouleas
5 papers · 5 as a resident
Bradley Monk
4 papers
Krishnansu Tewari
4 papers
Ronac Mamtani
4 papers
Alessandro Santin
3 papers
BB
Brian Baumann
3 papers · 3 as a resident
Justin Bekelman
3 papers · 3 as a resident
Kai Law
3 papers
Vivek Narayan
3 papers · 2 as a fellow

Clinical trials

Dovitinib in Neuroendocrine Tumors
Principal investigator · Completed · Phase 2
Abramson Cancer Center at Penn Medicine
2012–2016
Brivanib Metastatic Renal Cell Carcinoma
Principal investigator · Terminated · Phase 2
Abramson Cancer Center at Penn Medicine
2011–2013
Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney Cancer
Principal investigator · Completed
Abramson Cancer Center at Penn Medicine
2009–2018
NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma
Study chair · Terminated · Phase 2
PrECOG, LLC.
2012–2016